Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
about
Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.New clinical grading system for chronic GVHD predicts duration of systemic immunosuppressive treatment and GVHD-specific and overall survival.A case of chronic kidney disease with thrombotic microangiopathy in a hematopoietic stem cell transplant recipient.Late effects of blood and marrow transplantation.Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention.Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD).Prospective predictors of return to work in the 5 years after hematopoietic cell transplantationDonor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD ConsortiumPredictors of health-related quality of life in patients treated with auto- and allo-SCT for hematological malignancies.Impact of age on quality of life, functional status, and survival in patients with chronic graft-versus-host disease.Non-endocrine late complications of bone marrow transplantation in childhood: part II.Function, adjustment, quality of life and symptoms (FAQS) in allogeneic hematopoietic stem cell transplantation (HSCT) survivors: a study protocol.Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.Sirolimus demonstrates activity in the primary therapy of acute graft-versus-host disease without systemic glucocorticoids.Sensitivity of changes in chronic graft-versus-host disease activity to changes in patient-reported quality of life: results from the Chronic Graft-versus-Host Disease Consortium.Nonmalignant late effects and compromised functional status in survivors of hematopoietic cell transplantationNCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: health-related quality of life, functional, and neurocognitive outcomesSubsequent malignant neoplasms after hematopoietic cell transplantation.A multicenter feasibility study of chronic graft-versus-host disease according to the National Institute of Health criteria: efforts to establish a Brazil-Seattle consortium as a platform for future collaboration in clinical trials.Chronic graft versus host disease.Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study.Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation.Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.Which questionnaires should we use to evaluate quality of life in patients with chronic graft-vs-host disease?Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation.Health care utilization by adult Hispanic long-term survivors of hematopoietic stem cell transplantation: report from the Bone Marrow Transplant Survivor StudyQuality of life after allogeneic hematopoietic cell transplantation.Parental stress before, during, and after pediatric stem cell transplantation: a review article.Impaired physical function following pediatric LT.Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.Hematopoietic stem cell transplantation for curing children with severe autoimmune diseases: is this a valid option?Quality of Life in the Chronic GVHD Consortium Cohort: Lessons Learned and the Long Road Ahead.Allogeneic transplantation for CML in the TKI era: striking the right balance.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Patient-Centered Outcomes Working Group Report.Rehabilitative intervention during and after pediatric hematopoietic stem cell transplantation: An analysis of the existing literature.Resilience in patients after allogeneic stem cell transplantation.
P2860
Q30274960-E700A9B4-EDEB-4D97-A2F7-865C0C77EAD9Q33374835-7DCBCA00-FCB1-4375-AB63-C4B9E09B94E4Q33389589-327D4444-3797-472F-8818-3E581E397978Q33574136-A4EAD75B-A53D-4C54-A7C3-9EABE024F52EQ33606151-87F2DE4B-8B3F-4252-9E46-56606999A86DQ33608255-2ED306F8-F168-443A-B203-816335B20276Q33710708-9E76DBC3-910C-44E0-B712-7327EF89E5E9Q33774650-2EB26B2C-92AA-4A7A-AC35-132B5DA1D029Q33786982-6DE09FEE-BADE-47A4-BA99-4676E7C9B488Q33796976-0882BE54-2A90-4271-B932-C638933FE948Q33830644-045ACF77-722B-462F-836C-F6F87BFDBCEBQ33949546-CBA11D82-36CA-4201-AC62-B47F25584FB3Q34022803-BFE0321B-B86C-48C1-A555-E6B793620D61Q34722701-9518D77C-11EB-4C5C-AAEB-682A6023E695Q35003711-F636959E-0182-4270-AF5F-00BDE99E6C43Q35023409-33357036-F96C-423F-A83D-88A48AB446CEQ35193740-12F4B6A7-FED8-479C-933D-90C17CE66717Q35266002-EDC9E8E9-729D-4CCE-B1C5-DAF6C6B258C8Q35665096-26BEE99C-674A-43F4-92A7-08287EF9F539Q35672786-657C501C-6D46-46CD-9B35-20B5313A7BE6Q35678455-0CF9C913-EBB0-4957-810F-2084F8425D9FQ35748144-B2B9FCCF-CDE6-44AF-9509-4CCAABBF1975Q35772587-D5139E6C-586C-4468-AD3E-0712D75D4E44Q35847602-529B6C3A-1575-4609-9DA9-EC8DBDFD6075Q35849241-220223A1-CF59-4873-BEDD-518DBFECF9C6Q35920594-F715298A-18D2-443C-81C0-1DFB7EC6ED3BQ36141716-5DC88E36-437D-4707-9A49-84F7F88417D7Q36707816-28D73DCB-8B9D-4FC5-A003-3CF04DCD1ADCQ36712018-7EF21247-8EB4-422B-A180-5F5E74FE44A7Q37036339-FE0D7FA6-CB9D-437C-9C21-1C5E68691E25Q37262503-7D042883-E733-4D63-997F-72AD3A3540D5Q37418069-8468C784-9014-423A-BEAB-623B9933716AQ37457050-9B2C3CEF-E48F-45D5-A9C7-69FE28A7B019Q37580829-92A9DAA2-A8BE-44D7-AC3C-D66F971FCBEBQ38004048-37345414-7834-4C9E-B284-BB2ECE01BA6FQ38573015-F0567C04-47B2-47A1-8438-E8D849302AE1Q38634736-1B1DDFE2-C486-4FF4-8437-A55FA6F648E9Q38808511-B16A28E5-2C3E-491E-A9C4-11B87952414DQ38894979-A19F6F6E-F227-4935-9FF6-84B347E0B6C7Q39304819-63D27F00-0612-48C8-B081-B86D002A96DB
P2860
Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Health and functional status o ...... od and Marrow Transplantation.
@en
Health and functional status o ...... od and Marrow Transplantation.
@nl
type
label
Health and functional status o ...... od and Marrow Transplantation.
@en
Health and functional status o ...... od and Marrow Transplantation.
@nl
prefLabel
Health and functional status o ...... od and Marrow Transplantation.
@en
Health and functional status o ...... od and Marrow Transplantation.
@nl
P2093
P1476
Health and functional status o ...... od and Marrow Transplantation.
@en
P2093
Apperley JF
Tichelli A
van Lint MT
P304
P356
10.7326/0003-4819-126-3-199702010-00002
P407
P50
P577
1997-02-01T00:00:00Z